Trials / Completed
CompletedNCT01393860
Real-world Aliskiren Use in Diabetic Patients
Aliskiren Use in Diabetic Patients: Who's Using it, Why, and How is it Working ?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate real-world patterns of aliskiren use with a focus of change in renal function following aliskiren initiation as well as to identify "triggering events" that lead to aliskiren initiation.
Conditions
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2011-06-01
- First posted
- 2011-07-13
- Last updated
- 2011-07-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01393860. Inclusion in this directory is not an endorsement.